Lyell Immunopharma
(NASDAQ) LYEL
Lyell Immunopharma Financials at a Glance
Market Cap
$559.60M
Revenue (TTM)
$36.00K
Net Income (TTM)
$274.45M
EPS (TTM)
$-15.17
P/E Ratio
-1.58
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$24.44
Volume
3,104
Open
$23.90
Price
$24.44
Volume
3,104
Open
$23.90
Previous Close
$24.01
Daily Range
$23.41 - $24.44
52-Week Range
$7.65 - $45.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$24.44
Volume
3,104
Open
$23.90
Previous Close
$24.01
Daily Range
$23.41 - $24.44
52-Week Range
$7.65 - $45.00
LYEL News
LYEL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lyell Immunopharma
Industry
Biotechnology
Sector
Health CareEmployees
161
CEO
Lynn Seely, MD
Website
www.lyell.comHeadquarters
South San Francisco, CA 94080, US
LYEL Financials
Key Financial Metrics (TTM)
Gross Margin
-66%
Operating Margin
-5660%
Net Income Margin
-7624%
Return on Equity
-87%
Return on Capital
-70%
Return on Assets
-81%
Earnings Yield
-63.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$559.60M
Shares Outstanding
23.31M
Volume
3.10K
Short Interest
0.00%
Avg. Volume
101.22K
Financials (TTM)
Gross Profit
$11.50M
Operating Income
$203.77M
EBITDA
$192.24M
Operating Cash Flow
$150.02M
Capital Expenditure
$780.00K
Free Cash Flow
$150.80M
Cash & ST Invst.
$247.22M
Total Debt
$41.92M
Lyell Immunopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.00K
-45.5%
Gross Profit
$2.39M
-21836.4%
Gross Margin
-398.50%
N/A
Market Cap
$559.60M
N/A
Market Cap/Employee
$1.87M
N/A
Employees
300
N/A
Net Income
$140.72M
+26.7%
EBITDA
$59.47M
-3.2%
Quarterly Fundamentals
Net Cash
$205.30M
-34.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$41.92M
-17.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
-80.71%
N/A
Return on Invested Capital
-70.11%
N/A
Free Cash Flow
$61.19M
-29.4%
Operating Cash Flow
$60.83M
-28.8%